Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Carcinoma, Non-Small-Cell Lung
  • Mutation
  • Quinazolines
  • Receptor, Epidermal Growth Factor

abstract

  • EGFR mutations in NSCLC cells are associated with sensitivity to gefitinib but not to cetuximab.

publication date

  • August 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1093/jnci/dji238

PubMed ID

  • 16106023

Additional Document Info

start page

  • 1185

end page

  • 94

volume

  • 97

number

  • 16